Quantinno Capital Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$219K Sell
12,517
-16,239
-56% -$322K ﹤0.01% 3177
2025
Q4
$564K Buy
28,756
+20,145
+234% +$418K ﹤0.01% 2300
2025
Q3
$237K Buy
+8,611
New +$265K ﹤0.01% 2637
2021
Q1
Sell
-3,779
Closed -$291K 332
2020
Q4
$291K Buy
+3,779
New +$292K 0.23% 235
2020
Q1
Sell
-6,737
Closed -$529K 558
2019
Q4
$529K Buy
6,737
+3,047
+83% +$224K 0.33% 89
2019
Q3
$252K Buy
+3,690
New +$248K 0.17% 311
2019
Q2
Sell
-6,489
Closed -$544K 523
2019
Q1
$544K Buy
6,489
+4,082
+170% +$426K 0.35% 84
2018
Q4
$283K Buy
+2,407
New +$278K 0.23% 221

Other funds holding USNA

Quantinno Capital Management's USNA Position: Q1 2026 in Review

Quantinno Capital Management reduced its Usana Health Sciences (USNA) stake by 56% in Q1 2026, selling an estimated $322K and leaving 12,517 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #3177.

Quantinno Capital Management first reported a position in USNA in Q4 2018 and has held it in 8 quarters since. The position peaked at $564K in Q4 2025. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Quantinno Capital Management held 12,517 shares of Usana Health Sciences worth $219K as of Q1 2026.
  • Quantinno Capital Management sold 16,239 Usana Health Sciences shares in Q1 2026, an estimated $322K.
  • Usana Health Sciences made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3177 holding.
  • Quantinno Capital Management first reported a position in Usana Health Sciences in Q4 2018 and has held it in 8 quarters since.
  • Quantinno Capital Management's Usana Health Sciences position peaked at $564K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.